Pub Date : 2024-07-09Print Date: 2024-09-01DOI: 10.2460/ajvr.24.04.0110
Rebecca C Bishop, Sarah M Graham, Sara L Connolly, Pamela A Wilkins, Annette M McCoy
Objective: To optimize and evaluate methods for the detection of the inflammatory biomarkers myeloperoxidase (MPO) and calprotectin (CP) in equine feces by ELISA.
Animals: Healthy horses (n = 28) and horses with intestinal inflammation (n = 10).
Methods: Feces were suspended in buffer to create fecal supernatant. Serum and fecal supernatant were analyzed using ELISA kits validated for the detection of MPO and CP in equine serum. Assay validation steps included intra- and interassay variability (coefficient of variation [CV]), dilution linearity, spike recovery, and sample type correlation. Variations in sample handling protocols (centrifugation speed, extraction buffer, and filtration) were evaluated.
Results: 17 paired fecal and serum samples were used for initial analysis (10 healthy horses, 7 colitis). Previously reported sample handling protocols resulted in detectable MPO and CP but poor CV, linearity, and spike recovery. There was a linear correlation between serum and fecal samples for CP but not MPO. There was a significant difference between the concentration and CV of alternative sample handling protocols for CP and MPO, with improved CV for CP (2.1% to 18.6%) but not MPO (14.4% to 53.4%). Processing fresh feces with a fecal extraction buffer and filtration of supernatant resulted in the best CV (0.5% to 3.8%) and recovery (45% to 64%) for CP. Detection of MPO was inconsistent regardless of method.
Clinical relevance: There are few reliable diagnostic modalities for inflammation of the equine large colon. Findings support quantification of CP in equine feces using the described ELISA kit and protocol. With additional study to establish reference interval and clinical utility, the fecal inflammatory biomarker CP may allow for noninvasive quantification of intestinal inflammation in horses.
{"title":"Systematic evaluation supports the use of ELISA for quantification of calprotectin in equine feces, a first step toward noninvasive quantification of intestinal inflammation in horses.","authors":"Rebecca C Bishop, Sarah M Graham, Sara L Connolly, Pamela A Wilkins, Annette M McCoy","doi":"10.2460/ajvr.24.04.0110","DOIUrl":"10.2460/ajvr.24.04.0110","url":null,"abstract":"<p><strong>Objective: </strong>To optimize and evaluate methods for the detection of the inflammatory biomarkers myeloperoxidase (MPO) and calprotectin (CP) in equine feces by ELISA.</p><p><strong>Animals: </strong>Healthy horses (n = 28) and horses with intestinal inflammation (n = 10).</p><p><strong>Methods: </strong>Feces were suspended in buffer to create fecal supernatant. Serum and fecal supernatant were analyzed using ELISA kits validated for the detection of MPO and CP in equine serum. Assay validation steps included intra- and interassay variability (coefficient of variation [CV]), dilution linearity, spike recovery, and sample type correlation. Variations in sample handling protocols (centrifugation speed, extraction buffer, and filtration) were evaluated.</p><p><strong>Results: </strong>17 paired fecal and serum samples were used for initial analysis (10 healthy horses, 7 colitis). Previously reported sample handling protocols resulted in detectable MPO and CP but poor CV, linearity, and spike recovery. There was a linear correlation between serum and fecal samples for CP but not MPO. There was a significant difference between the concentration and CV of alternative sample handling protocols for CP and MPO, with improved CV for CP (2.1% to 18.6%) but not MPO (14.4% to 53.4%). Processing fresh feces with a fecal extraction buffer and filtration of supernatant resulted in the best CV (0.5% to 3.8%) and recovery (45% to 64%) for CP. Detection of MPO was inconsistent regardless of method.</p><p><strong>Clinical relevance: </strong>There are few reliable diagnostic modalities for inflammation of the equine large colon. Findings support quantification of CP in equine feces using the described ELISA kit and protocol. With additional study to establish reference interval and clinical utility, the fecal inflammatory biomarker CP may allow for noninvasive quantification of intestinal inflammation in horses.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-09Print Date: 2024-09-01DOI: 10.2460/ajvr.24.03.0076
Megan N Brobst, Bailey A Abi-Nader, Sarah J Blasczynski, Munashe Chigerwe
Objective: To determine the accuracy of a continuous glucose monitoring system (CGMS) device by comparing glucose concentrations measured over time as determined by the CGMS to those of the chemistry analyzer (reference method).
Animals: 7 healthy goats and 7 dairy calves.
Methods: A randomized, crossover design with 3 treatments: control, hypoglycemia, and hyperglycemia. The CGMS device was applied to the neck. Hypoglycemia and hyperglycemia were induced by insulin and xylazine, respectively. Glucose concentrations were measured by the chemistry analyzer CGMS, point-of-care glucometer, and intensive care unit machine at 0 (before treatment), 2, 4, 6, 8, 10, and 12 hours. Agreement between the CGMS and the chemistry analyzer was determined by Bland-Altman plots. The analytical and clinical accuracy of the CGMS was determined using the International Organization for Standardization (ISO) 15197:2013 criteria and the Parkes error grid analysis.
Results: In goats, the CGMS overestimated glucose concentrations during the hypoglycemic, normoglycemia, and hyperglycemia treatments. In calves, the CGMS underestimated glucose concentrations during the hypoglycemic treatment but overestimated glucose concentrations in normoglycemia and hyperglycemic treatments. The CGMS met the ISO clinical accuracy criteria for goats and calves, with > 99% of the glucose measurements in zones A and B of the Parkes grid. However, the CGMS did not meet the ISO 15197:2013 criteria for analytical accuracy.
Clinical relevance: The CGMS evaluated in our study only met the ISO 15197:2013 clinical accuracy criteria, not the analytical accuracy. Therefore, the device might be considered for clinical use.
目的:通过比较连续葡萄糖监测系统(CGMS)和化学分析仪(参考方法)测定的葡萄糖浓度,确定连续葡萄糖监测系统(CGMS)的准确性:通过比较连续葡萄糖监测系统(CGMS)与化学分析仪(参考方法)测定的葡萄糖浓度,确定连续葡萄糖监测系统(CGMS)设备的准确性:方法:采用随机交叉设计,3 种处理方法:对照组、低血糖组和高血糖组。CGMS装置应用于颈部。分别用胰岛素和异丙嗪诱导低血糖和高血糖。分别在 0 小时(治疗前)、2 小时、4 小时、6 小时、8 小时、10 小时和 12 小时用 CGMS 化学分析仪、护理点血糖仪和重症监护室机器测量血糖浓度。CGMS 与化学分析仪之间的一致性由 Bland-Altman 图确定。采用国际标准化组织 (ISO) 15197:2013 标准和 Parkes 误差网格分析法确定 CGMS 的分析和临床准确性:结果:在低血糖、正常血糖和高血糖处理过程中,CGMS 高估了山羊的血糖浓度。在犊牛身上,CGMS 低估了低血糖治疗时的血糖浓度,但高估了正常血糖和高血糖治疗时的血糖浓度。对于山羊和犊牛,CGMS 符合 ISO 临床准确度标准,99% 以上的葡萄糖测量值位于 Parkes 网格的 A 区和 B 区。但是,CGMS 的分析准确度不符合 ISO 15197:2013 标准:我们研究中评估的 CGMS 只符合 ISO 15197:2013 临床准确性标准,不符合分析准确性标准。因此,该设备可考虑用于临床。
{"title":"Evaluation of a continuous glucose monitoring system in healthy dairy calves and adult goats.","authors":"Megan N Brobst, Bailey A Abi-Nader, Sarah J Blasczynski, Munashe Chigerwe","doi":"10.2460/ajvr.24.03.0076","DOIUrl":"10.2460/ajvr.24.03.0076","url":null,"abstract":"<p><strong>Objective: </strong>To determine the accuracy of a continuous glucose monitoring system (CGMS) device by comparing glucose concentrations measured over time as determined by the CGMS to those of the chemistry analyzer (reference method).</p><p><strong>Animals: </strong>7 healthy goats and 7 dairy calves.</p><p><strong>Methods: </strong>A randomized, crossover design with 3 treatments: control, hypoglycemia, and hyperglycemia. The CGMS device was applied to the neck. Hypoglycemia and hyperglycemia were induced by insulin and xylazine, respectively. Glucose concentrations were measured by the chemistry analyzer CGMS, point-of-care glucometer, and intensive care unit machine at 0 (before treatment), 2, 4, 6, 8, 10, and 12 hours. Agreement between the CGMS and the chemistry analyzer was determined by Bland-Altman plots. The analytical and clinical accuracy of the CGMS was determined using the International Organization for Standardization (ISO) 15197:2013 criteria and the Parkes error grid analysis.</p><p><strong>Results: </strong>In goats, the CGMS overestimated glucose concentrations during the hypoglycemic, normoglycemia, and hyperglycemia treatments. In calves, the CGMS underestimated glucose concentrations during the hypoglycemic treatment but overestimated glucose concentrations in normoglycemia and hyperglycemic treatments. The CGMS met the ISO clinical accuracy criteria for goats and calves, with > 99% of the glucose measurements in zones A and B of the Parkes grid. However, the CGMS did not meet the ISO 15197:2013 criteria for analytical accuracy.</p><p><strong>Clinical relevance: </strong>The CGMS evaluated in our study only met the ISO 15197:2013 clinical accuracy criteria, not the analytical accuracy. Therefore, the device might be considered for clinical use.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-09Print Date: 2024-09-01DOI: 10.2460/ajvr.24.04.0102
Jade A Peralta, Douglas S Carithers, Frederik Beugnet, Michael R Lappin
Objective: To cohouse cats experimentally infected with Bartonella clarridgeiae (Bc) with naive cats in a flea-free environment or with Ctenocephalides felis, Bartonella henselae (Bh), Mycoplasma haemofelis, and Candidatus Mycoplasma haemominutum to determine which flea could be a vector and to assess whether transmission of the infectious agents could be blocked by fipronil and (S)-methoprene.
Animals: Specific pathogen-free cats (n = 34).
Methods: In experiment 1, Bc was inoculated in 1 cat that was housed with 9 naive cats without C felis. In experiment 2, the 2 cats inoculated with Bc were housed with 6 other cats (2 inoculated with Bh, 2 inoculated with M haemofelis, and 2 inoculated with Candidatus M haemominutum) in the center (enclosure 2) of 3 housing enclosures separated by mesh walls that allow passage of fleas but precludes fighting. C felis were placed only on cats in enclosure 2 (5 times). Cats in enclosures 1 (n = 8) and 2 (8) were untreated, and cats in enclosure 3 (8) were administered fipronil and (S)-methoprene. Blood was collected from all cats for PCR assays for the pathogens.
Results: None of the cats housed with the cat inoculated with Bc became PCR positive in the absence of C felis. All cats in enclosure 2 became Bc DNA positive. While 2 of 8 cats in enclosure 1 became Bc PCR positive, none of the treated cats in enclosure 3 became infected.
Clinical relevance: The study demonstrated that C felis can be a vector for Bc. The results support the recommendation that flea control products can reduce the risk of transmission of flea-borne pathogens.
目的将实验性感染了克拉里奇氏巴顿氏菌(Bc)的猫与无跳蚤环境中的天真猫或感染了栉头蚤、鸡巴顿氏菌(Bh)、血型支原体和血型支原体的猫同舍饲养,以确定哪种跳蚤可能是病媒,并评估氟虫腈和(S)-甲氧苄啶是否能阻断传染源的传播:动物:无特定病原体的猫(n = 34):在实验 1 中,将 Bc 接种到 1 只与 9 只没有感染 Celis 的天真猫一起饲养的猫身上。在实验 2 中,接种了 Bc 的 2 只猫与另外 6 只猫(接种了 Bh 的 2 只、接种了 M haemofelis 的 2 只、接种了 M haemominutum 的 2 只)一起饲养在 3 个围栏的中间(围栏 2),围栏之间用网墙隔开,网墙允许跳蚤通过,但不允许打斗。只在围栏 2 中的猫身上放置了猫鼬噬菌体(5 次)。围栏 1(8 只)和围栏 2(8 只)中的猫未经处理,围栏 3(8 只)中的猫则施用了氟虫腈和(S)-灭多威。采集了所有猫的血液,用于病原体的 PCR 检测:结果:在没有猫科动物白喉杆菌的情况下,与接种了白喉杆菌的猫一起饲养的猫都没有出现 PCR 阳性。围栏 2 中的所有猫的 Bc DNA 都呈阳性。围栏 1 中的 8 只猫中有 2 只呈 Bc PCR 阳性,而围栏 3 中经过治疗的猫没有一只受到感染:临床相关性:该研究表明,猫鼬可能是 Bc 的传播媒介。临床意义:该研究表明,猫鼬噬菌体可能是乙型肝炎病毒的传播媒介,研究结果支持了关于跳蚤控制产品可降低跳蚤传播病原体风险的建议。
{"title":"Fipronil and (S)-methoprene can lessen the risk of transmission of Bartonella clarridgeiae among cats with exposure to Ctenocephalides felis.","authors":"Jade A Peralta, Douglas S Carithers, Frederik Beugnet, Michael R Lappin","doi":"10.2460/ajvr.24.04.0102","DOIUrl":"10.2460/ajvr.24.04.0102","url":null,"abstract":"<p><strong>Objective: </strong>To cohouse cats experimentally infected with Bartonella clarridgeiae (Bc) with naive cats in a flea-free environment or with Ctenocephalides felis, Bartonella henselae (Bh), Mycoplasma haemofelis, and Candidatus Mycoplasma haemominutum to determine which flea could be a vector and to assess whether transmission of the infectious agents could be blocked by fipronil and (S)-methoprene.</p><p><strong>Animals: </strong>Specific pathogen-free cats (n = 34).</p><p><strong>Methods: </strong>In experiment 1, Bc was inoculated in 1 cat that was housed with 9 naive cats without C felis. In experiment 2, the 2 cats inoculated with Bc were housed with 6 other cats (2 inoculated with Bh, 2 inoculated with M haemofelis, and 2 inoculated with Candidatus M haemominutum) in the center (enclosure 2) of 3 housing enclosures separated by mesh walls that allow passage of fleas but precludes fighting. C felis were placed only on cats in enclosure 2 (5 times). Cats in enclosures 1 (n = 8) and 2 (8) were untreated, and cats in enclosure 3 (8) were administered fipronil and (S)-methoprene. Blood was collected from all cats for PCR assays for the pathogens.</p><p><strong>Results: </strong>None of the cats housed with the cat inoculated with Bc became PCR positive in the absence of C felis. All cats in enclosure 2 became Bc DNA positive. While 2 of 8 cats in enclosure 1 became Bc PCR positive, none of the treated cats in enclosure 3 became infected.</p><p><strong>Clinical relevance: </strong>The study demonstrated that C felis can be a vector for Bc. The results support the recommendation that flea control products can reduce the risk of transmission of flea-borne pathogens.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christopher Outcalt, Sarah Nesbella, Sue VandeWoude, Kristen Browning-Blas
{"title":"Novel Innovations for Tissue Regeneration in Osteoarthritis charged: Colorado State veterinary scientists partner on impactful osteoarthritis research.","authors":"Christopher Outcalt, Sarah Nesbella, Sue VandeWoude, Kristen Browning-Blas","doi":"10.2460/ajvr.24.06.0168","DOIUrl":"10.2460/ajvr.24.06.0168","url":null,"abstract":"","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141557842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Iowa State University: on the case.","authors":"David Gieseke","doi":"10.2460/ajvr.24.06.0179","DOIUrl":"10.2460/ajvr.24.06.0179","url":null,"abstract":"","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141557841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To develop an innovative process for stereotactic brain biopsies in dogs and cats that would provide a definitive diagnosis and optimize the management of patients with brain lesions.
Animals: 4 dogs and 1 cat diagnosed with 1 or more brain lesion(s) underwent brain biopsies between March 24, 2023, and October 25, 2023.
Methods: Based on trajectories selected on images of MRI and CT scan performed on each patient, a computerized software program was used to design a 3-D-printed patient-specific device with maxillary dental impression located on a baseplate to secure the patient's head and with insertion ports for the biopsy instrumentations located on a C-arm. As proof of concept, the device was successfully used in 2 cadavers before being used on clinical patients. All biopsy samples were submitted for histopathological examination.
Results: Histological diagnosis was obtained in 80% (4/5) of the cases (choroid plexus tumor, astrocytoma, meningioma, and chronic meningoencephalitis of unknown origin). In 1 patient, the results of biopsy were nondiagnostic; postmortem diagnosis was consistent with a low-grade oligodendroglioma. All the patients were discharged within 24 hours after the procedure without complications. This novel stereotactic system allows the surgeon to perform safe, easy-to-use, inexpensive, and minimally invasive precise brain biopsies in dogs and cats, without complications.
Clinical relevance: This unique technique could be applied to any size and type of skull and for any type of brain lesions and would provide diagnostic information that would be valuable for future treatment planning and prognosis.
目的:为狗和猫的立体定向脑活检开发一种创新流程,以提供明确诊断并优化脑部病变患者的治疗:开发一种创新的犬猫立体定向脑活检流程,为脑部病变患者提供明确诊断并优化管理。动物:在2023年3月24日至2023年10月25日期间,4只犬和1只猫被诊断出患有一个或多个脑部病变,并接受了脑活检:根据在每位患者的核磁共振成像和 CT 扫描图像上选择的轨迹,使用计算机软件程序设计了一种 3-D 打印的患者专用装置,该装置带有上颌牙印模,位于固定患者头部的底板上,并带有位于 C 型臂上的活检器械插入口。作为概念验证,该装置在用于临床患者之前,已在两具尸体上成功使用。所有活检样本均提交组织病理学检查:结果:80%(4/5)的病例获得了组织学诊断(脉络丛肿瘤、星形细胞瘤、脑膜瘤和不明原因的慢性脑膜脑炎)。有一名患者的活检结果无法确诊,死后诊断为低级别少突胶质细胞瘤。所有患者均在术后 24 小时内出院,未出现并发症。这种新型立体定向系统可让外科医生对猫狗进行安全、易用、廉价和微创的精确脑活检,且无并发症:这项独特的技术可用于任何大小和类型的头骨以及任何类型的脑损伤,并可提供对未来治疗计划和预后有价值的诊断信息。
{"title":"Using a three-dimensional-printed device with the patient's maxillary dental impression allows to perform minimally invasive brain biopsies in dogs and cats: a preliminary study.","authors":"Sabrina Fert, Hadrien Frankar, Alice Dussaux, Clémence Berthomé, Steeve Chantrel, Laurent Cauzinille","doi":"10.2460/ajvr.24.04.0122","DOIUrl":"10.2460/ajvr.24.04.0122","url":null,"abstract":"<p><strong>Objective: </strong>To develop an innovative process for stereotactic brain biopsies in dogs and cats that would provide a definitive diagnosis and optimize the management of patients with brain lesions.</p><p><strong>Animals: </strong>4 dogs and 1 cat diagnosed with 1 or more brain lesion(s) underwent brain biopsies between March 24, 2023, and October 25, 2023.</p><p><strong>Methods: </strong>Based on trajectories selected on images of MRI and CT scan performed on each patient, a computerized software program was used to design a 3-D-printed patient-specific device with maxillary dental impression located on a baseplate to secure the patient's head and with insertion ports for the biopsy instrumentations located on a C-arm. As proof of concept, the device was successfully used in 2 cadavers before being used on clinical patients. All biopsy samples were submitted for histopathological examination.</p><p><strong>Results: </strong>Histological diagnosis was obtained in 80% (4/5) of the cases (choroid plexus tumor, astrocytoma, meningioma, and chronic meningoencephalitis of unknown origin). In 1 patient, the results of biopsy were nondiagnostic; postmortem diagnosis was consistent with a low-grade oligodendroglioma. All the patients were discharged within 24 hours after the procedure without complications. This novel stereotactic system allows the surgeon to perform safe, easy-to-use, inexpensive, and minimally invasive precise brain biopsies in dogs and cats, without complications.</p><p><strong>Clinical relevance: </strong>This unique technique could be applied to any size and type of skull and for any type of brain lesions and would provide diagnostic information that would be valuable for future treatment planning and prognosis.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141490611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-28Print Date: 2024-09-01DOI: 10.2460/ajvr.24.03.0082
Kendra N Fletcher, Mindy E Bergman, Jonathan W Austin, Steven L Marks, Roger B Fingland, Barbara Dallap-Schaer, Chris Sanchez, Ruthanne Chun, Elizabeth G Davis, Garam Kim, Yanai Y Otero La Porte, Emma I Edoga, Jonathan M Levine
Objective: Referencing growing concerns over the recruitment and retention of faculty in academic veterinary medicine, the authors hypothesized that among surveyed veterinary residents and early-career faculty, work-life balance and workplace climate and culture are stronger motivators than financial considerations, regardless of demographic factors such as gender, race/ethnicity, and area of specialization.
Sample: 541 participants were included in data analysis.
Methods: A mixed methods approach was utilized, incorporating both quantitative data and qualitative, free-text responses to better understand veterinary career choices by contextualizing factors associated with academic medicine.
Results: Factors underpinning career-related decision-making were ranked by level of importance as (1) workplace environment/culture, (2) personal well-being/work-life balance, (3) salary and bonuses, (4) geographic location, (5) facilities and resources, (6) benefits, and (7) schedule flexibility. Desires for workload balance, schedule flexibility, support from leadership, and mentorship and collaboration were among the top themes of qualitative responses for both residents and early career faculty respondents. Factors influencing career decision-making for resident and early-career faculty are varied. Workplace environment, work-life balance, and schedule flexibility are areas that academic institutions can address and continue to improve and that are likely to positively impact entry into academia and the desire to stay.
Clinical relevance: This study sought to understand factors related to career decision-making and interest in academic veterinary medicine among residents and early-career faculty. Understanding these factors can support efforts to recruit and retain faculty in academic veterinary medicine.
{"title":"Survey indicates addressing workplace environment, work-life balance, and flexibility are key to attracting and retaining veterinarians in academia.","authors":"Kendra N Fletcher, Mindy E Bergman, Jonathan W Austin, Steven L Marks, Roger B Fingland, Barbara Dallap-Schaer, Chris Sanchez, Ruthanne Chun, Elizabeth G Davis, Garam Kim, Yanai Y Otero La Porte, Emma I Edoga, Jonathan M Levine","doi":"10.2460/ajvr.24.03.0082","DOIUrl":"10.2460/ajvr.24.03.0082","url":null,"abstract":"<p><strong>Objective: </strong>Referencing growing concerns over the recruitment and retention of faculty in academic veterinary medicine, the authors hypothesized that among surveyed veterinary residents and early-career faculty, work-life balance and workplace climate and culture are stronger motivators than financial considerations, regardless of demographic factors such as gender, race/ethnicity, and area of specialization.</p><p><strong>Sample: </strong>541 participants were included in data analysis.</p><p><strong>Methods: </strong>A mixed methods approach was utilized, incorporating both quantitative data and qualitative, free-text responses to better understand veterinary career choices by contextualizing factors associated with academic medicine.</p><p><strong>Results: </strong>Factors underpinning career-related decision-making were ranked by level of importance as (1) workplace environment/culture, (2) personal well-being/work-life balance, (3) salary and bonuses, (4) geographic location, (5) facilities and resources, (6) benefits, and (7) schedule flexibility. Desires for workload balance, schedule flexibility, support from leadership, and mentorship and collaboration were among the top themes of qualitative responses for both residents and early career faculty respondents. Factors influencing career decision-making for resident and early-career faculty are varied. Workplace environment, work-life balance, and schedule flexibility are areas that academic institutions can address and continue to improve and that are likely to positively impact entry into academia and the desire to stay.</p><p><strong>Clinical relevance: </strong>This study sought to understand factors related to career decision-making and interest in academic veterinary medicine among residents and early-career faculty. Understanding these factors can support efforts to recruit and retain faculty in academic veterinary medicine.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The disinfection efficiency of disinfectants differs in specific conditions. This study aimed to investigate the disinfection efficiency of commercial hydrogen peroxide, chlorine dioxide, and chlorine disinfectant on real field surfaces and provide data for precise disinfection.
Methods: Simulated field disinfection and field disinfection methods were conducted to quantitatively evaluate the disinfection efficiency of hydrogen peroxide, chlorine dioxide, and sodium dichloroisocyanurate. The log10 reduction of biological indicators, Escherichia coli (ATCC 8099) and Staphylococcus aureus (ATCC 6538), was calculated. Next, the reduction in natural bacteria on the surfaces of a food production and processing workshop and a biosafety laboratory was determined.
Results: The 3 commercial disinfectants evaluated were effective against E coli and S aureus, with a reduction of more than 3.00 log10 colony-forming units/mL tested for an exposure time of 15 minutes with 3.5% hydrogen peroxide, 100 mg/L chlorine dioxide, and 250 mg/L sodium dichloroisocyanurate. The natural load in the food production and processing workshop decreased by more than 90% using 10.5% hydrogen peroxide with an exposure time of 30 minutes. The same disinfection level in the biosafety level 2 laboratory was achieved by 500 mg/L chlorine dioxide at an exposure time of 60 minutes and 450 mg/L sodium dichloroisocyanurate at 60 minutes.
Clinical relevance: This study provides a reference for precise disinfection of surfaces in the food industry and biosafety laboratories.
{"title":"Investigation of the disinfection efficiency of commercial hydrogen peroxide, chlorine dioxide, and chlorine disinfectant on different surfaces.","authors":"Chunai Tao, Xiaolan Tang, Yongxin Gan, Yun Qin, Shuting Yang, Fengshun Huang","doi":"10.2460/ajvr.24.03.0079","DOIUrl":"10.2460/ajvr.24.03.0079","url":null,"abstract":"<p><strong>Objective: </strong>The disinfection efficiency of disinfectants differs in specific conditions. This study aimed to investigate the disinfection efficiency of commercial hydrogen peroxide, chlorine dioxide, and chlorine disinfectant on real field surfaces and provide data for precise disinfection.</p><p><strong>Methods: </strong>Simulated field disinfection and field disinfection methods were conducted to quantitatively evaluate the disinfection efficiency of hydrogen peroxide, chlorine dioxide, and sodium dichloroisocyanurate. The log10 reduction of biological indicators, Escherichia coli (ATCC 8099) and Staphylococcus aureus (ATCC 6538), was calculated. Next, the reduction in natural bacteria on the surfaces of a food production and processing workshop and a biosafety laboratory was determined.</p><p><strong>Results: </strong>The 3 commercial disinfectants evaluated were effective against E coli and S aureus, with a reduction of more than 3.00 log10 colony-forming units/mL tested for an exposure time of 15 minutes with 3.5% hydrogen peroxide, 100 mg/L chlorine dioxide, and 250 mg/L sodium dichloroisocyanurate. The natural load in the food production and processing workshop decreased by more than 90% using 10.5% hydrogen peroxide with an exposure time of 30 minutes. The same disinfection level in the biosafety level 2 laboratory was achieved by 500 mg/L chlorine dioxide at an exposure time of 60 minutes and 450 mg/L sodium dichloroisocyanurate at 60 minutes.</p><p><strong>Clinical relevance: </strong>This study provides a reference for precise disinfection of surfaces in the food industry and biosafety laboratories.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-28Print Date: 2024-09-01DOI: 10.2460/ajvr.24.02.0027
Jaechun Cho, Soo-Yeon Jeong, Min-Suk Kim, Wang Sik Cho, Dong-Wook Kim, Chul Park
Objective: To improve the current recommendations for the diagnosis of canine heartworm (Dirofilaria immitis) disease.
Animals: Blood samples collected from 35 shelter dogs in the Republic of Korea.
Methods: Samples were tested for the presence of microfilaria using the modified Knott (MK) test and D immitis DNA using species-specific loop-mediated isothermal amplification (LAMP) PCR. The blood samples were additionally assessed for the presence of heartworm antigens using the Antigen Rapid Canine Heartworm AG Test Kit 2.0 (Bionote Co). The performance of the MK test and LAMP PCR was assessed through statistical analysis, with a paired McNemar test utilized for comparison.
Results: The heartworm antigen was detected in 28.5% of the subjects. Of the 10 positive animals, the MK test detected microfilaria in 4 of 35 (11.4%) animals, and LAMP PCR detected D immitis DNA in 6 of 35 (17.1%). The results of this study indicate that the LAMP PCR showed more positive results in samples compared to the conventional MK test.
Clinical relevance: The D immitis-specific LAMP PCR assay has the potential to function as an alternative to current detection methods. It could complement the existing antigen detection tests in diagnosing canine heartworm infections.
{"title":"Loop-mediated isothermal amplification polymerase chain reaction in place of a modified Knott test in screening dogs for heartworm (Dirofilaria immitis) infection combined with antigen detection test.","authors":"Jaechun Cho, Soo-Yeon Jeong, Min-Suk Kim, Wang Sik Cho, Dong-Wook Kim, Chul Park","doi":"10.2460/ajvr.24.02.0027","DOIUrl":"10.2460/ajvr.24.02.0027","url":null,"abstract":"<p><strong>Objective: </strong>To improve the current recommendations for the diagnosis of canine heartworm (Dirofilaria immitis) disease.</p><p><strong>Animals: </strong>Blood samples collected from 35 shelter dogs in the Republic of Korea.</p><p><strong>Methods: </strong>Samples were tested for the presence of microfilaria using the modified Knott (MK) test and D immitis DNA using species-specific loop-mediated isothermal amplification (LAMP) PCR. The blood samples were additionally assessed for the presence of heartworm antigens using the Antigen Rapid Canine Heartworm AG Test Kit 2.0 (Bionote Co). The performance of the MK test and LAMP PCR was assessed through statistical analysis, with a paired McNemar test utilized for comparison.</p><p><strong>Results: </strong>The heartworm antigen was detected in 28.5% of the subjects. Of the 10 positive animals, the MK test detected microfilaria in 4 of 35 (11.4%) animals, and LAMP PCR detected D immitis DNA in 6 of 35 (17.1%). The results of this study indicate that the LAMP PCR showed more positive results in samples compared to the conventional MK test.</p><p><strong>Clinical relevance: </strong>The D immitis-specific LAMP PCR assay has the potential to function as an alternative to current detection methods. It could complement the existing antigen detection tests in diagnosing canine heartworm infections.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-28Print Date: 2024-08-01DOI: 10.2460/ajvr.24.01.0012
Iman Y Zaghloul, Daniela Bedenice, Michelle L Ceresia, Pilar Hermida Jones, Alfredo Sanchez-Londono, Mitchell N Lobo, Mark Böhlke, Mary Rose Paradis
Objective: To evaluate the effects of aging on phenylbutazone (PBZ) disposition in older horses (≥ 25 years old) compared to young adults (4 to 10 years old) by characterizing the pharmacokinetic profile of PBZ and its active metabolite, oxyphenbutazone (OPBZ), following a 2.2-mg/kg dose, IV. We hypothesized that the disposition of PBZ will be affected by age.
Animals: 16 healthy horses (8 young adults aged 4 to 10 years and 8 geriatric horses ≥ 25 years old).
Methods: Horses were administered a single 2.2-mg/kg PBZ dose, IV. Plasma samples were collected at designated time points and frozen at -80 °C until assayed using liquid chromatography-tandem mass spectrometry. Pharmacokinetic analyses were performed using Phoenix WinNonlin, version 8.0 (Certara). Both clinical and pharmacokinetic data were compared between age groups using independent samples t tests, with P < .05 considered significant.
Results: Baseline characteristics did not differ between groups, with the exception of age, weight, and plasma total solids. Plasma concentrations of PBZ were best described by a two-compartment model. The maximum plasma concentration of OPBZ was reached at 5 hours for both age groups, and the metabolite-to-parent-drug area-under-the-curve ratios were approximately 20% for both groups. None of the pharmacokinetic parameters of PBZ or its metabolite, OPBZ, differed significantly between age groups.
Clinical relevance: The hypothesis was rejected as there was no significant difference in PBZ disposition in young-adult horses compared to geriatric horses. Our data do not support the need for dose adjustments of PBZ in clinically healthy geriatric horses.
{"title":"Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses.","authors":"Iman Y Zaghloul, Daniela Bedenice, Michelle L Ceresia, Pilar Hermida Jones, Alfredo Sanchez-Londono, Mitchell N Lobo, Mark Böhlke, Mary Rose Paradis","doi":"10.2460/ajvr.24.01.0012","DOIUrl":"10.2460/ajvr.24.01.0012","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effects of aging on phenylbutazone (PBZ) disposition in older horses (≥ 25 years old) compared to young adults (4 to 10 years old) by characterizing the pharmacokinetic profile of PBZ and its active metabolite, oxyphenbutazone (OPBZ), following a 2.2-mg/kg dose, IV. We hypothesized that the disposition of PBZ will be affected by age.</p><p><strong>Animals: </strong>16 healthy horses (8 young adults aged 4 to 10 years and 8 geriatric horses ≥ 25 years old).</p><p><strong>Methods: </strong>Horses were administered a single 2.2-mg/kg PBZ dose, IV. Plasma samples were collected at designated time points and frozen at -80 °C until assayed using liquid chromatography-tandem mass spectrometry. Pharmacokinetic analyses were performed using Phoenix WinNonlin, version 8.0 (Certara). Both clinical and pharmacokinetic data were compared between age groups using independent samples t tests, with P < .05 considered significant.</p><p><strong>Results: </strong>Baseline characteristics did not differ between groups, with the exception of age, weight, and plasma total solids. Plasma concentrations of PBZ were best described by a two-compartment model. The maximum plasma concentration of OPBZ was reached at 5 hours for both age groups, and the metabolite-to-parent-drug area-under-the-curve ratios were approximately 20% for both groups. None of the pharmacokinetic parameters of PBZ or its metabolite, OPBZ, differed significantly between age groups.</p><p><strong>Clinical relevance: </strong>The hypothesis was rejected as there was no significant difference in PBZ disposition in young-adult horses compared to geriatric horses. Our data do not support the need for dose adjustments of PBZ in clinically healthy geriatric horses.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}